Intrinsic value of Community Health Systems - CYH

Previous Close

$3.27

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$3.27

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of CYH stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  15,660
  16,020
  16,432
  16,894
  17,406
  17,968
  18,580
  19,243
  19,956
  20,722
  21,542
  22,416
  23,347
  24,336
  25,386
  26,498
  27,676
  28,921
  30,237
  31,626
  33,092
  34,638
  36,268
  37,985
  39,793
  41,697
  43,701
  45,810
  48,029
  50,362
Variable operating expenses, $m
  11,516
  11,770
  12,061
  12,387
  12,748
  13,144
  13,576
  14,043
  14,546
  15,086
  15,192
  15,808
  16,465
  17,163
  17,903
  18,688
  19,518
  20,396
  21,324
  22,304
  23,338
  24,428
  25,577
  26,788
  28,064
  29,406
  30,820
  32,307
  33,872
  35,517
Fixed operating expenses, $m
  3,976
  4,063
  4,152
  4,244
  4,337
  4,433
  4,530
  4,630
  4,732
  4,836
  4,942
  5,051
  5,162
  5,275
  5,392
  5,510
  5,631
  5,755
  5,882
  6,011
  6,144
  6,279
  6,417
  6,558
  6,702
  6,850
  7,000
  7,154
  7,312
  7,473
Total operating expenses, $m
  15,492
  15,833
  16,213
  16,631
  17,085
  17,577
  18,106
  18,673
  19,278
  19,922
  20,134
  20,859
  21,627
  22,438
  23,295
  24,198
  25,149
  26,151
  27,206
  28,315
  29,482
  30,707
  31,994
  33,346
  34,766
  36,256
  37,820
  39,461
  41,184
  42,990
Operating income, $m
  168
  187
  219
  264
  321
  392
  474
  570
  678
  800
  1,408
  1,557
  1,720
  1,898
  2,091
  2,301
  2,526
  2,770
  3,031
  3,311
  3,611
  3,931
  4,274
  4,639
  5,027
  5,441
  5,881
  6,349
  6,845
  7,372
EBITDA, $m
  1,330
  1,364
  1,415
  1,480
  1,560
  1,655
  1,765
  1,889
  2,029
  2,185
  2,356
  2,543
  2,748
  2,969
  3,209
  3,467
  3,745
  4,043
  4,362
  4,703
  5,068
  5,456
  5,870
  6,311
  6,779
  7,277
  7,805
  8,365
  8,960
  9,589
Interest expense (income), $m
  930
  890
  750
  773
  800
  830
  864
  901
  941
  984
  1,031
  1,081
  1,135
  1,192
  1,253
  1,317
  1,386
  1,459
  1,536
  1,618
  1,704
  1,795
  1,891
  1,992
  2,098
  2,211
  2,329
  2,454
  2,585
  2,723
  2,868
Earnings before tax, $m
  -722
  -563
  -554
  -536
  -509
  -472
  -426
  -371
  -306
  -231
  327
  422
  528
  645
  774
  914
  1,067
  1,234
  1,413
  1,607
  1,816
  2,041
  2,282
  2,540
  2,816
  3,112
  3,427
  3,764
  4,122
  4,504
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  88
  114
  143
  174
  209
  247
  288
  333
  382
  434
  490
  551
  616
  686
  760
  840
  925
  1,016
  1,113
  1,216
Net income, $m
  -722
  -563
  -554
  -536
  -509
  -472
  -426
  -371
  -306
  -231
  238
  308
  385
  471
  565
  668
  779
  901
  1,032
  1,173
  1,326
  1,490
  1,666
  1,854
  2,056
  2,272
  2,502
  2,747
  3,009
  3,288

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  17,796
  18,205
  18,673
  19,198
  19,780
  20,419
  21,114
  21,867
  22,678
  23,548
  24,479
  25,473
  26,530
  27,655
  28,847
  30,112
  31,450
  32,865
  34,360
  35,939
  37,605
  39,362
  41,214
  43,165
  45,220
  47,383
  49,660
  52,057
  54,578
  57,230
Adjusted assets (=assets-cash), $m
  17,796
  18,205
  18,673
  19,198
  19,780
  20,419
  21,114
  21,867
  22,678
  23,548
  24,479
  25,473
  26,530
  27,655
  28,847
  30,112
  31,450
  32,865
  34,360
  35,939
  37,605
  39,362
  41,214
  43,165
  45,220
  47,383
  49,660
  52,057
  54,578
  57,230
Revenue / Adjusted assets
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
  0.880
Average production assets, $m
  10,618
  10,862
  11,141
  11,454
  11,802
  12,183
  12,597
  13,047
  13,530
  14,050
  14,605
  15,198
  15,829
  16,500
  17,212
  17,966
  18,764
  19,609
  20,501
  21,443
  22,437
  23,485
  24,590
  25,754
  26,980
  28,271
  29,629
  31,059
  32,563
  34,146
Working capital, $m
  1,206
  1,234
  1,265
  1,301
  1,340
  1,384
  1,431
  1,482
  1,537
  1,596
  1,659
  1,726
  1,798
  1,874
  1,955
  2,040
  2,131
  2,227
  2,328
  2,435
  2,548
  2,667
  2,793
  2,925
  3,064
  3,211
  3,365
  3,527
  3,698
  3,878
Total debt, $m
  11,712
  12,080
  12,501
  12,974
  13,498
  14,073
  14,699
  15,376
  16,106
  16,889
  17,727
  18,621
  19,573
  20,585
  21,659
  22,796
  24,001
  25,274
  26,620
  28,041
  29,540
  31,122
  32,788
  34,544
  36,394
  38,341
  40,390
  42,547
  44,816
  47,203
Total liabilities, $m
  16,016
  16,384
  16,805
  17,278
  17,802
  18,377
  19,003
  19,680
  20,410
  21,193
  22,031
  22,925
  23,877
  24,889
  25,963
  27,100
  28,305
  29,578
  30,924
  32,345
  33,844
  35,426
  37,092
  38,848
  40,698
  42,645
  44,694
  46,851
  49,120
  51,507
Total equity, $m
  1,780
  1,820
  1,867
  1,920
  1,978
  2,042
  2,111
  2,187
  2,268
  2,355
  2,448
  2,547
  2,653
  2,765
  2,885
  3,011
  3,145
  3,286
  3,436
  3,594
  3,760
  3,936
  4,121
  4,316
  4,522
  4,738
  4,966
  5,206
  5,458
  5,723
Total liabilities and equity, $m
  17,796
  18,204
  18,672
  19,198
  19,780
  20,419
  21,114
  21,867
  22,678
  23,548
  24,479
  25,472
  26,530
  27,654
  28,848
  30,111
  31,450
  32,864
  34,360
  35,939
  37,604
  39,362
  41,213
  43,164
  45,220
  47,383
  49,660
  52,057
  54,578
  57,230
Debt-to-equity ratio
  6.580
  6.640
  6.700
  6.760
  6.820
  6.890
  6.960
  7.030
  7.100
  7.170
  7.240
  7.310
  7.380
  7.440
  7.510
  7.570
  7.630
  7.690
  7.750
  7.800
  7.860
  7.910
  7.960
  8.000
  8.050
  8.090
  8.130
  8.170
  8.210
  8.250
Adjusted equity ratio
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -722
  -563
  -554
  -536
  -509
  -472
  -426
  -371
  -306
  -231
  238
  308
  385
  471
  565
  668
  779
  901
  1,032
  1,173
  1,326
  1,490
  1,666
  1,854
  2,056
  2,272
  2,502
  2,747
  3,009
  3,288
Depreciation, amort., depletion, $m
  1,162
  1,178
  1,196
  1,216
  1,239
  1,263
  1,290
  1,319
  1,351
  1,385
  948
  987
  1,028
  1,071
  1,118
  1,167
  1,218
  1,273
  1,331
  1,392
  1,457
  1,525
  1,597
  1,672
  1,752
  1,836
  1,924
  2,017
  2,115
  2,217
Funds from operations, $m
  439
  615
  641
  680
  730
  791
  864
  949
  1,045
  1,154
  1,187
  1,295
  1,413
  1,542
  1,683
  1,834
  1,998
  2,174
  2,363
  2,566
  2,783
  3,015
  3,262
  3,527
  3,808
  4,107
  4,426
  4,764
  5,124
  5,505
Change in working capital, $m
  24
  28
  32
  36
  39
  43
  47
  51
  55
  59
  63
  67
  72
  76
  81
  86
  91
  96
  101
  107
  113
  119
  125
  132
  139
  147
  154
  162
  171
  180
Cash from operations, $m
  416
  587
  610
  644
  690
  748
  817
  898
  990
  1,095
  1,124
  1,228
  1,342
  1,466
  1,602
  1,748
  1,907
  2,078
  2,262
  2,459
  2,670
  2,896
  3,137
  3,394
  3,669
  3,961
  4,272
  4,602
  4,953
  5,325
Maintenance CAPEX, $m
  -676
  -689
  -705
  -723
  -744
  -766
  -791
  -818
  -847
  -879
  -912
  -948
  -987
  -1,028
  -1,071
  -1,118
  -1,167
  -1,218
  -1,273
  -1,331
  -1,392
  -1,457
  -1,525
  -1,597
  -1,672
  -1,752
  -1,836
  -1,924
  -2,017
  -2,115
New CAPEX, $m
  -206
  -244
  -279
  -313
  -347
  -381
  -415
  -449
  -484
  -519
  -556
  -593
  -631
  -671
  -712
  -754
  -798
  -844
  -892
  -942
  -994
  -1,048
  -1,105
  -1,164
  -1,226
  -1,291
  -1,359
  -1,430
  -1,504
  -1,582
Cash from investing activities, $m
  -882
  -933
  -984
  -1,036
  -1,091
  -1,147
  -1,206
  -1,267
  -1,331
  -1,398
  -1,468
  -1,541
  -1,618
  -1,699
  -1,783
  -1,872
  -1,965
  -2,062
  -2,165
  -2,273
  -2,386
  -2,505
  -2,630
  -2,761
  -2,898
  -3,043
  -3,195
  -3,354
  -3,521
  -3,697
Free cash flow, $m
  -466
  -347
  -375
  -393
  -401
  -400
  -389
  -369
  -341
  -303
  -344
  -314
  -276
  -232
  -181
  -123
  -58
  15
  96
  186
  284
  391
  507
  634
  770
  918
  1,077
  1,248
  1,432
  1,629
Issuance/(repayment) of debt, $m
  -2,201
  368
  421
  473
  524
  575
  626
  677
  730
  783
  838
  894
  952
  1,012
  1,074
  1,138
  1,204
  1,274
  1,346
  1,421
  1,499
  1,581
  1,667
  1,756
  1,849
  1,947
  2,050
  2,157
  2,269
  2,387
Issuance/(repurchase) of shares, $m
  3,269
  604
  601
  589
  567
  536
  496
  446
  387
  318
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  1,068
  972
  1,022
  1,062
  1,091
  1,111
  1,122
  1,123
  1,117
  1,101
  838
  894
  952
  1,012
  1,074
  1,138
  1,204
  1,274
  1,346
  1,421
  1,499
  1,581
  1,667
  1,756
  1,849
  1,947
  2,050
  2,157
  2,269
  2,387
Total cash flow (excl. dividends), $m
  602
  626
  647
  669
  690
  711
  733
  754
  776
  798
  494
  581
  676
  779
  892
  1,014
  1,146
  1,289
  1,442
  1,606
  1,783
  1,972
  2,174
  2,390
  2,620
  2,865
  3,127
  3,405
  3,701
  4,015
Retained Cash Flow (-), $m
  -3,269
  -604
  -601
  -589
  -567
  -536
  -496
  -446
  -387
  -318
  -93
  -99
  -106
  -112
  -119
  -126
  -134
  -142
  -150
  -158
  -167
  -176
  -185
  -195
  -205
  -216
  -228
  -240
  -252
  -265
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -2,667
  22
  46
  80
  123
  175
  237
  308
  389
  480
  401
  481
  570
  667
  773
  888
  1,013
  1,147
  1,292
  1,449
  1,616
  1,796
  1,989
  2,194
  2,414
  2,649
  2,899
  3,165
  3,449
  3,750
Discount rate, %
  15.00
  15.75
  16.54
  17.36
  18.23
  19.14
  20.10
  21.11
  22.16
  23.27
  24.43
  25.66
  26.94
  28.28
  29.70
  31.18
  32.74
  34.38
  36.10
  37.90
  39.80
  41.79
  43.88
  46.07
  48.38
  50.80
  53.34
  56.00
  58.80
  61.74
PV of cash for distribution, $m
  -2,319
  16
  29
  42
  53
  61
  66
  67
  64
  59
  36
  31
  26
  20
  16
  12
  8
  6
  4
  2
  1
  1
  0
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  50.0
  37.3
  28.1
  21.3
  16.5
  13.0
  10.4
  8.6
  7.3
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4
  6.4

Community Health Systems, Inc. is an operator of general acute care hospitals and outpatient facilities in communities across the country. The Company operates through hospital operations segment, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services. The Company provides healthcare services through the hospitals that it owns and operates and affiliated businesses in non-urban and selected urban markets throughout the United States. The services provided through its hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. The Company also provides additional outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers, and home health and hospice agencies.

FINANCIAL RATIOS  of  Community Health Systems (CYH)

Valuation Ratios
P/E Ratio -0.2
Price to Sales 0
Price to Book 0.2
Price to Tangible Book
Price to Cash Flow 0.3
Price to Free Cash Flow 0.9
Growth Rates
Sales Growth Rate -5.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -21.9%
Cap. Spend. - 3 Yr. Gr. Rate 3.9%
Financial Strength
Quick Ratio 1
Current Ratio 0.2
LT Debt to Equity 915.7%
Total Debt to Equity 943.9%
Interest Coverage -1
Management Effectiveness
Return On Assets -3.5%
Ret/ On Assets - 3 Yr. Avg. 0.9%
Return On Total Capital -9.1%
Ret/ On T. Cap. - 3 Yr. Avg. -2.6%
Return On Equity -61.1%
Return On Equity - 3 Yr. Avg. -18.2%
Asset Turnover 0.8
Profitability Ratios
Gross Margin 83.7%
Gross Margin - 3 Yr. Avg. 84.2%
EBITDA Margin 1.7%
EBITDA Margin - 3 Yr. Avg. 9.1%
Operating Margin -4.8%
Oper. Margin - 3 Yr. Avg. 2.9%
Pre-Tax Margin -9.3%
Pre-Tax Margin - 3 Yr. Avg. -1.8%
Net Profit Margin -9.3%
Net Profit Margin - 3 Yr. Avg. -2.7%
Effective Tax Rate 6.1%
Eff/ Tax Rate - 3 Yr. Avg. 19.4%
Payout Ratio 0%

CYH stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CYH stock intrinsic value calculation we used $15353 million for the last fiscal year's total revenue generated by Community Health Systems. The default revenue input number comes from 0001 income statement of Community Health Systems. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CYH stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 15%, whose default value for CYH is calculated based on our internal credit rating of Community Health Systems, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Community Health Systems.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CYH stock the variable cost ratio is equal to 73.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $3890 million in the base year in the intrinsic value calculation for CYH stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 6.4% for Community Health Systems.

Corporate tax rate of 27% is the nominal tax rate for Community Health Systems. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CYH stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CYH are equal to 67.8%.

Life of production assets of 15.4 years is the average useful life of capital assets used in Community Health Systems operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CYH is equal to 7.7%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $-767 million for Community Health Systems - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 116.254 million for Community Health Systems is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Community Health Systems at the current share price and the inputted number of shares is $0.4 billion.

RELATED COMPANIES Price Int.Val. Rating
HCA HCA Healthcare 132.70 41.29  str.sell
UHS Universal Heal 126.03 135.61  hold
THC Tenet Healthca 28.38 33.79  hold
LPNT LifePoint Heal 64.40 79.01  buy
SEM Select Medical 18.55 90.59  str.buy

COMPANY NEWS

▶ Princeton Baptist Medical Center names new CEO   [Sep-06-18 02:03PM  American City Business Journals]
▶ Health system that owes CHS more than $28 million files for bankruptcy   [Sep-04-18 03:39PM  American City Business Journals]
▶ Scorecard: CHS investor calls for Wayne Smith's ouster   [Aug-30-18 12:47PM  American City Business Journals]
▶ Three Nashville execs named among the most influential in health care   [Aug-24-18 08:41AM  American City Business Journals]
▶ NYU plans free tuition for medical school students   [Aug-17-18 02:24PM  Yahoo Finance Video]
▶ CHS under investigation related to federal incentive program   [Aug-14-18 08:04AM  American City Business Journals]
▶ CHS CEO Wayne Smith says company is on the right track   [Jul-27-18 03:57PM  American City Business Journals]
▶ Community Health Systems: 2Q Earnings Snapshot   [Jul-26-18 04:39PM  Associated Press]
▶ Why Community Health Systems, Inc. Jumped 14.4% Today   [Jul-23-18 03:51PM  Motley Fool]
▶ CHS stock price hits all-time low   [Jul-17-18 03:11PM  American City Business Journals]
▶ CHS offers notes to pay off more than $1 billion in debt   [11:13AM  American City Business Journals]
▶ [$$] Community Health Systems Completes Debt Swap   [03:59PM  The Wall Street Journal]
▶ First look: A post-Ikea future quickly emerges for $1.7B development   [May-31-18 03:34PM  American City Business Journals]
▶ Developers: Ikea deal is dead, but our $1.7B project is not   [May-30-18 01:39PM  American City Business Journals]
▶ Look inside the retirement paycheck of Quorum's former CEO   [May-25-18 03:12PM  American City Business Journals]
▶ [$$] Community Health Extends Deadline for Debt Swap   [May-23-18 01:20PM  The Wall Street Journal]
▶ Why health care will cost you more next year   [May-22-18 01:22PM  Yahoo Finance Video]
▶ CEO steps down at CHS spinoff company   [May-21-18 10:56AM  American City Business Journals]
▶ Scorecard: How CHS' rocky year impacted CEO Wayne Smith's paycheck   [May-17-18 12:05PM  American City Business Journals]
▶ Community Health Systems Announces Exchange Offers   [May-05-18 12:13AM  Business Wire]
▶ Following layoffs, CHS' Wayne Smith talks cost-cutting   [May-02-18 03:35PM  American City Business Journals]
▶ [$$] Community Health Launches Debt Exchange   [10:37AM  The Wall Street Journal]
▶ Community Health Systems Announces Proposed Exchange Offers   [May-01-18 08:00PM  Business Wire]
▶ Community Health Systems: 1Q Earnings Snapshot   [05:00PM  Associated Press]
▶ CHS sells Florida medical center   [Apr-19-18 12:55PM  American City Business Journals]
▶ CHS lays off dozens of corporate employees   [Apr-12-18 05:24PM  American City Business Journals]
▶ Scorecard: Activist investor appears ready to take on CHS   [Apr-06-18 06:00AM  American City Business Journals]
▶ Dade City hospital renamed as Adventist takes over   [Apr-02-18 12:54PM  American City Business Journals]
▶ [$$] Community Health Clinches Key Loan Amendment   [Mar-26-18 03:03PM  The Wall Street Journal]
▶ [$$] Community Health Brings on Stable of Advisers to Aid in Refinancing   [Mar-16-18 01:29PM  The Wall Street Journal]
▶ Wayne Smith says CHS to sell more hospitals in 2018   [Feb-28-18 03:40PM  American City Business Journals]
▶ Community Health posts smaller-than-expected loss   [Feb-27-18 06:15PM  Reuters]
▶ Community Health Systems posts 4Q loss   [05:07PM  Associated Press]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.